LABD

$12.70 2.34% $0.29
Jun 16, 2026 04:00 AM

LABD, or Direxion Daily S&P Biotech Bear 3X Shares, is an exchange-traded fund (ETF) designed to provide three times the inverse of the daily performance of the S&P Biotechnology Select Industry Index. LABD seeks to deliver -3x the daily return of the underlying index.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Jun 17, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Supercharge Your LABD Trading Now

Empower your trading with ohlcx.com. Our comprehensive platform delivers precise analysis and strategic insights for LABD, designed to improve your trading outcomes. Boost your investment success with us and unlock new opportunities with our advanced system!

Enhance Your Trading Now

Frequently Asked Questions

Factors influencing LABD’s performance include movements in the biotech sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. LABD’s daily rebalancing and compounding effects also impact performance.

Historical performance data for LABD includes past returns, NAV, and volatility. Investors should review performance charts and reports to understand LABD's track record in achieving its leveraged inverse objective.

LABD typically distributes dividends on a quarterly basis. These dividends come from income generated by the underlying securities, although leveraged ETFs like LABD may have lower yields compared to non-leveraged funds.

Investors can buy shares of LABD through a brokerage account. The ETF is traded on major stock exchanges under the ticker symbol "LABD" and can be bought and sold like other stocks and ETFs.

LABD rebalances its holdings daily to maintain its -3x leverage ratio relative to the S&P Biotechnology Select Industry Index. This daily rebalancing ensures that the ETF remains aligned with its -3x daily performance target, though it can result in performance deviations over longer periods due to compounding effects.

Risks include high volatility and potential for significant losses due to LABD’s leveraged inverse exposure. The ETF's performance is highly sensitive to daily movements in the biotech sector, and leverage can amplify both gains and losses.

Similar ETFs to LABD include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide 3x the daily performance of the S&P Biotechnology Select Industry Index, the opposite of LABD’s objective; XBI (SPDR S&P Biotech ETF), which provides exposure to the biotechnology sector without leverage; and BIB (Direxion Daily S&P Biotech Bull 2X Shares), which provides 2x the daily performance of the S&P Biotechnology Select Industry Index, less leveraged compared to LABD.

LABD uses leverage to amplify its inverse exposure to the biotech sector, targeting -3x the daily performance of the S&P Biotechnology Select Industry Index. Leverage can lead to significant performance fluctuations, particularly over periods longer than one day due to compounding effects.

LABD has an expense ratio of approximately 1.07%. This fee covers the costs of managing the fund, including administrative and operational expenses, expressed as a percentage of the fund’s average net assets.

LABD is managed by Direxion Funds and employs leverage through financial instruments such as futures contracts, options, and swap agreements. The fund aims to maintain its -3x leverage ratio through daily rebalancing.

Transform Your LABD Trading Now

Transform your approach to trading with OHLCX.com. Our automated system offers detailed metrics and technical analysis for LABD, tailored to enhance your trading performance. Transform your trading strategy now and elevate your strategy.

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.